The U.S. antimicrobial plastics market was estimated at around USD 662 million in 2013. It is predicted to rise through the projected phase, at about 9 percent CAGR. This phase lasts till 2020 from 2014. The market is likely to achieve around USD 1, 227 million by the end of the phase.
Antimicrobial plastics decrease the wearing away and augment the longevity of healthcare commodities. Expansion in the market of medical devices in the United States of America is driving the demand for the U.S. antimicrobial plastics market in the coming few years.
Moreover, growth in infections acquired from hospitals is also likely to increase the U.S. antimicrobial plastics market.